Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes

Progress in Lipid Research

Volumn 54, Issue 1, 2014, Pages 86-112

  Sahini, Nishika ^a   Borlak, Jürgen ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cellular cross talks; Hepatocyte; Lipid droplets; Lipotoxicity; Metabolic syndrome; Non alcoholic fatty liver disease (NAFLD)

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BIOLOGICAL MARKER; CAVEOLIN; CCAAT ENHANCER BINDING PROTEIN; CD36 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EXENDIN 4; FAT DROPLET; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; HORMONE RECEPTOR BLOCKING AGENT; LIVER FATTY ACID BINDING PROTEIN; LIVER X RECEPTOR ALPHA; LONG CHAIN FATTY ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 1 ANTAGONIST; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RAB PROTEIN; RETINOID X RECEPTOR; SNARE PROTEIN; SPIRONOLACTONE; TAUROURSODEOXYCHOLIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL TYPE; CROSS LINKING; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ACTIVITY; ENDOPLASMIC RETICULUM STRESS; ENDOSOME; ENDOTHELIUM CELL; FATP GENE; FATTY ACID SYNTHESIS; FATTY LIVER; FIBROBLAST; GENE; GENE EXPRESSION REGULATION; GOLGI COMPLEX; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KUPFFER CELL; LIPID ANALYSIS; LIPID COMPOSITION; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; LIPOGENESIS; LIPOLYSIS; LIPOTOXICITY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER FAT; LIVER INJURY; LIVER SINUSOID ENDOTHELIAL CELL; LYMPHOCYTE; MACROPHAGE; MACROVESICULAR STEATOSIS; MEMBRANE TRANSPORT; METABOLIC SYNDROME X; MICROVESICULAR STEATOSIS; MITOCHONDRION; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OMENTUM; PARENCHYMA; PATHOGENESIS; PEROXISOME; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; REVIEW; SIGNAL TRANSDUCTION;

CELLULAR CROSS TALKS; HEPATOCYTE; LIPID DROPLETS; LIPOTOXICITY; METABOLIC SYNDROME; NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD);

ANIMALS; FATTY LIVER; HEPATOCYTES; LIPID METABOLISM; LIVER; METABOLIC SYNDROME X; SIGNAL TRANSDUCTION;

EID: 84896991817     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2014.02.002     Document Type: Review

References (325)

1. S. Stephen, A. Baranova, and Z.M. Younossi Nonalcoholic fatty liver disease and bariatric surgery Expert Rev Gastroenterol Hepatol 6 2012 163 171
2. K. Reue A thematic review series: lipid droplet storage and metabolism: from yeast to man J Lipid Res 52 2011 1865 1868
3. D.J. Murphy The dynamic roles of intracellular lipid droplets: from archaea to mammals Protoplasma 249 2012 541 585
4. L. Kuerschner, C. Moessinger, and C. Thiele Imaging of lipid biosynthesis: how a neutral lipid enters lipid droplets Traffic 9 2008 338 352 (Pubitemid 351188994)
5. S. Murphy, S. Martin, and R.G. Parton Quantitative analysis of lipid droplet fusion: inefficient steady state fusion but rapid stimulation by chemical fusogens PLoS One 5 2010 e15030
6. T.C. Walther, and R.V. Farese Jr. Lipid droplets and cellular lipid metabolism Annu Rev Biochem 81 2012 687 714
7. T. Okumura Role of lipid droplet proteins in liver steatosis J Physiol Biochem 67 2011 629 636
8. B.K. Straub, P. Stoeffel, H. Heid, R. Zimbelmann, and P. Schirmacher Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis Hepatology 47 2008 1936 1946 (Pubitemid 351945561)
9. Y. Guo, T.C. Walther, M. Rao, N. Stuurman, G. Goshima, and K. Terayama et al. Functional genomic screen reveals genes involved in lipid-droplet formation and utilization Nature 453 2008 657 661 (Pubitemid 351769298)
10. S. Sato, M. Fukasawa, Y. Yamakawa, T. Natsume, T. Suzuki, and I. Shoji et al. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein J Biochem 139 2006 921 930 (Pubitemid 44014586)
11. J.D. Browning, and J.D. Horton Molecular mediators of hepatic steatosis and liver injury J Clin Invest 114 2004 147 152 (Pubitemid 39071617)
12. J.S. Lee, R. Mendez, H.H. Heng, Z.Q. Yang, and K. Zhang Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation Am J Transl Res 4 2012 102 113
13. P. Pettinelli, A.M. Obregon, and L.A. Videla Molecular mechanisms of steatosis in nonalcoholic fatty liver disease Nutr Hosp 26 2011 441 450
14. X. Zhang, and K. Zhang Endoplasmic reticulum stress-associated lipid droplet formation and type II diabetes Biochem Res Int 2012 2012 247275
15. R. Lomonaco, N.E. Sunny, F. Bril, and K. Cusi Nonalcoholic fatty liver disease: current issues and novel treatment approaches Drugs 73 2013 1 14
16. J.M. Schattenberg, and D. Schuppan Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic Curr Opin Lipidol 22 2011 479 488
17. N. Anderson, and J. Borlak Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis Pharmacol Rev 60 2008 311 357
18. G. Marchesini, and R. Marzocchi Metabolic syndrome and NASH Clin Liver Dis 11 2007 105 117 ix (Pubitemid 46829976)
19. S. Mitsutake, K. Zama, H. Yokota, T. Yoshida, M. Tanaka, and M. Mitsui et al. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes J Biol Chem 286 2011 28544 28555
20. K.G. Jackson, V. Maitin, D.S. Leake, P. Yaqoob, and C.M. Williams Saturated fat-induced changes in Sf 60-400 particle composition reduces uptake of LDL by HepG2 cells J Lipid Res 47 2006 393 403 (Pubitemid 43276925)
21. J. Twisk, D.L. Gillian-Daniel, A. Tebon, L. Wang, P.H. Barrett, and A.D. Attie The role of the LDL receptor in apolipoprotein B secretion J Clin Invest 105 2000 521 532
22. J.R. Simard, B.K. Pillai, and J.A. Hamilton Fatty acid flip-flop in a model membrane is faster than desorption into the aqueous phase Biochemistry 47 2008 9081 9089
23. J.A. Hamilton Fast flip-flop of cholesterol and fatty acids in membranes: implications for membrane transport proteins Curr Opin Lipidol 14 2003 263 271 (Pubitemid 36688205)
24. C. Postic, R. Dentin, P.D. Denechaud, and J. Girard ChREBP, a transcriptional regulator of glucose and lipid metabolism Annu Rev Nutr 27 2007 179 192 (Pubitemid 351373354)
25. J. Krammer, M. Digel, F. Ehehalt, W. Stremmel, J. Fullekrug, and R. Ehehalt Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells Int J Med Sci 8 2011 599 614
26. M. Poppelreuther, B. Rudolph, C. Du, R. Grossmann, M. Becker, and C. Thiele et al. The N-terminal region of acyl-CoA synthetase 3 is essential for both the localization on lipid droplets and the function in fatty acid uptake J Lipid Res 53 2012 888 900
27. J.M. Orellana-Gavalda, L. Herrero, M.I. Malandrino, A. Paneda, M. Sol Rodriguez-Pena, and H. Petry et al. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation Hepatology 53 2011 821 832
28. Q. Wang, L. Jiang, J. Wang, S. Li, Y. Yu, and J. You et al. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice Hepatology 49 2009 1166 1175
29. Z.Z. Li, M. Berk, T.M. McIntyre, and A.E. Feldstein Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase J Biol Chem 284 2009 5637 5644
30. T. Kobayashi, D. Zadravec, and A. Jacobsson ELOVL2 overexpression enhances triacylglycerol synthesis in 3T3-L1 and F442A cells FEBS Lett 581 2007 3157 3163 (Pubitemid 46977355)
31. D. Zadravec, A. Brolinson, R.M. Fisher, C. Carneheim, R.I. Csikasz, and J. Bertrand-Michel et al. Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity FASEB J 24 2010 4366 4377
32. C.D. Green, C.G. Ozguden-Akkoc, Y. Wang, D.B. Jump, and L.K. Olson Role of fatty acid elongases in determination of de novo synthesized monounsaturated fatty acid species J Lipid Res 51 2010 1871 1877
33. Y.A. Moon, R.E. Hammer, and J.D. Horton Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice J Lipid Res 50 2009 412 423
34. X. Buque, M.J. Martinez, A. Cano, M.E. Miquilena-Colina, C. Garcia-Monzon, and P. Aspichueta et al. A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats J Lipid Res 51 2010 500 513
35. A. Garcia, M.M. Ihrig, R.C. Fry, Y. Feng, S. Xu, and S.R. Boutin et al. Genetic susceptibility to chronic hepatitis is inherited codominantly in Helicobacter hepaticus-infected AB6F1 and B6AF1 hybrid male mice, and progression to hepatocellular carcinoma is linked to hepatic expression of lipogenic genes and immune function-associated networks Infect Immun 76 2008 1866 1876 (Pubitemid 351656120)
36. H. Huang, A.L. McIntosh, G.G. Martin, A.D. Petrescu, K.K. Landrock, and D. Landrock et al. Inhibitors of fatty acid synthesis induce PPAR alpha-regulated fatty acid beta-oxidative genes: synergistic roles of L-FABP and glucose PPAR Res 2013 2013 865604
37. J. Laurencikiene, and M. Ryden Liver X receptors and fat cell metabolism Int J Obes Lond 36 2012 1494 1502
38. G.P. Ables Update on ppargamma and nonalcoholic fatty liver disease PPAR Res 2012 2012 912351
39. Evans Zachary P, Ellett Justin D, Chavin Kenneth D. Current Enzyme Inhibition 2008:100-8.
40. X. Du, Q.R. Wang, E. Chan, M. Merchant, J. Liu, and D. French et al. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth Cancer Res 72 2012 5843 5855
41. J. Qi, W. Lang, J.G. Geisler, P. Wang, I. Petrounia, and S. Mai et al. The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2 J Lipid Res 53 2012 1106 1116
42. V.A. Zammit Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia Biochem J 451 2013 1 12
43. Stone SJ. Mammalian diacylglycerol acyltransferases. The AOCS Lipid Library [Internet]; June 2011. < http://lipidlibrary.aocs.org/animbio/dgat/ index.htm > [cited 19.11.2013].
44. H.R. Wurie, L. Buckett, and V.A. Zammit Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells FEBS J 279 2012 3033 3047
45. D.L. Brasaemle, and N.E. Wolins Packaging of fat: an evolving model of lipid droplet assembly and expansion J Biol Chem 287 2012 2273 2279
46. J.J. Liang, P. Oelkers, C. Guo, P.C. Chu, J.L. Dixon, and H.N. Ginsberg et al. Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells J Biol Chem 279 2004 44938 44944 (Pubitemid 39430907)
47. C.C. Chang, N. Sakashita, K. Ornvold, O. Lee, E.T. Chang, and R. Dong et al. Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine J Biol Chem 275 2000 28083 28092
48. O. Lee, C.C. Chang, W. Lee, and T.Y. Chang Immunodepletion experiments suggest that acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-1) protein plays a major catalytic role in adult human liver, adrenal gland, macrophages, and kidney, but not in intestines J Lipid Res 39 1998 1722 1727 (Pubitemid 28377938)
49. R.G. Lee, M.C. Willingham, M.A. Davis, K.A. Skinner, and L.L. Rudel Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates J Lipid Res 41 2000 1991 2001 (Pubitemid 32038994)
50. P. Parini, M. Davis, A.T. Lada, S.K. Erickson, T.L. Wright, and U. Gustafsson et al. ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver Circulation 110 2004 2017 2023 (Pubitemid 39331916)
51. L.L. Rudel, R.G. Lee, and T.L. Cockman Acyl coenzyme A:cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis Curr Opin Lipidol 12 2001 121 127 (Pubitemid 32242919)
52. Fillimore N, Alrob OA, Lopaschuk GD. Fatty acid β oxidation. The AOCS Lipid Library [Internet]; July 2011. < http://lipidlibrary.aocs.org/ animbio/faoxid/index.htm > [cited 19.11.2013].
53. B.K. Smith, S.S. Jain, S. Rimbaud, A. Dam, J. Quadrilatero, and R. Ventura-Clapier et al. FAT/CD36 is located on the outer mitochondrial membrane, upstream of long-chain acyl-CoA synthetase, and regulates palmitate oxidation Biochem J 437 2011 125 134
54. M. Febbraio CD36 goes native Arterioscler Thromb Vasc Biol 28 2008 1209 1210
55. V. Luangrath, M.R. Brodeur, D. Rhainds, and L. Brissette Mouse CD36 has opposite effects on LDL and oxidized LDL metabolism in vivo Arterioscler Thromb Vasc Biol 28 2008 1290 1295
56. L.P. Bechmann, R.K. Gieseler, J.P. Sowa, A. Kahraman, J. Erhard, and I. Wedemeyer et al. Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis Liver Int 30 2010 850 859
57. F. Nassir, O.L. Adewole, E.M. Brunt, and N.A. Abumrad CD36 deletion reduces VLDL secretion, modulates liver prostaglandin levels and exacerbates hepatic steatosis in ob/ob mice J Lipid Res 2013
58. M.E. Miquilena-Colina, E. Lima-Cabello, S. Sanchez-Campos, M.V. Garcia-Mediavilla, M. Fernandez-Bermejo, and T. Lozano-Rodriguez et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C Gut 60 2011 1394 1402
59. P. Degrace, B. Moindrot, I. Mohamed, J. Gresti, Z.Y. Du, and J.M. Chardigny et al. Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10, cis-12 conjugated linoleic acid J Lipid Res 47 2006 2647 2655 (Pubitemid 44936078)
60. D.P. Koonen, R.L. Jacobs, M. Febbraio, M.E. Young, C.L. Soltys, and H. Ong et al. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity Diabetes 56 2007 2863 2871 (Pubitemid 350223619)
61. T. Hajri, X.X. Han, A. Bonen, and N.A. Abumrad Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice J Clin Invest 109 2002 1381 1389 (Pubitemid 34546903)
62. J.F. Glatz, J.J. Luiken, and A. Bonen Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease Physiol Rev 90 2010 367 417
63. H. Noushmehr, E. D'Amico, L. Farilla, H. Hui, K.A. Wawrowsky, and W. Mlynarski et al. Fatty acid translocase (FAT/CD36) is localized on insulin-containing granules in human pancreatic beta-cells and mediates fatty acid effects on insulin secretion Diabetes 54 2005 472 481
64. D. Calvo, D. Gomez-Coronado, Y. Suarez, M.A. Lasuncion, and M.A. Vega Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL J Lipid Res 39 1998 777 788 (Pubitemid 28163280)
65. J. Zhou, M. Febbraio, T. Wada, Y. Zhai, R. Kuruba, and J. He et al. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis Gastroenterology 134 2008 556 567
66. Y. Kawano, S. Nishiumi, S. Tanaka, K. Nobutani, A. Miki, and Y. Yano et al. Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport Arch Biochem Biophys 504 2010 221 227
67. J.H. Lee, T. Wada, M. Febbraio, J. He, T. Matsubara, and M.J. Lee et al. A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis Gastroenterology 139 2010 653 663
68. Y. Fan, G.P. Boivin, E.S. Knudsen, D.W. Nebert, Y. Xia, and A. Puga The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis Cancer Res 70 2010 212 220
69. A.L. McIntosh, B.P. Atshaves, D. Landrock, K.K. Landrock, G.G. Martin, and S.M. Storey et al. Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female mice Lipids 48 2013 435 448
70. T. Velkov Interactions between human liver fatty acid binding protein and peroxisome proliferator activated receptor selective drugs PPAR Res 2013 2013 938401
71. J. Storch, and L. McDermott Structural and functional analysis of fatty acid-binding proteins J Lipid Res 50 Suppl 2009 S126 S131
72. H.A. Hostetler, A.L. McIntosh, B.P. Atshaves, S.M. Storey, H.R. Payne, and A.B. Kier et al. L-FABP directly interacts with PPARalpha in cultured primary hepatocytes J Lipid Res 50 2009 1663 1675
73. C. Schachtrup, S. Malcharek, J.J. Haitsma, B. Lachmann, Y. Owada, and B. Binas et al. Activation of PPARgamma reverses a defect of surfactant synthesis in mice lacking two types of fatty acid binding protein Biochim Biophys Acta 1781 2008 314 320
74. C. Guzman, M. Benet, S. Pisonero-Vaquero, M. Moya, M.V. Garcia-Mediavilla, and M.L. Martinez-Chantar et al. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARalpha; and repressed by C/EBPalpha: implications in FABP1 down-regulation in nonalcoholic fatty liver disease Biochim Biophys Acta 1831 2013 803 818
75. B. Relja, M. Szermutzky, D. Henrich, M. Maier, J.J. de Haan, and T. Lubbers et al. Intestinal-FABP and liver-FABP: novel markers for severe abdominal injury Acad Emerg Med 17 2010 729 735
76. R.E. Gimeno Fatty acid transport proteins Curr Opin Lipidol 18 2007 271 276 (Pubitemid 46743050)
77. A. Falcon, H. Doege, A. Fluitt, B. Tsang, N. Watson, and M.A. Kay et al. FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase Am J Physiol Endocrinol Metab 299 2010 E384 E393
78. S.J. Mihalik, S.J. Steinberg, Z. Pei, J. Park, D.G. Kim, and A.K. Heinzer et al. Participation of two members of the very long-chain acyl-CoA synthetase family in bile acid synthesis and recycling J Biol Chem 277 2002 24771 24779 (Pubitemid 34952009)
79. B. Nie, H.M. Park, M. Kazantzis, M. Lin, A. Henkin, and S. Ng et al. Specific bile acids inhibit hepatic fatty acid uptake in mice Hepatology 56 2012 1300 1310
80. L.P. Bechmann, R.A. Hannivoort, G. Gerken, G.S. Hotamisligil, M. Trauner, and A. Canbay The interaction of hepatic lipid and glucose metabolism in liver diseases J Hepatol 56 2012 952 964
81. T.Q. Truong, D. Aubin, L. Falstrault, M.R. Brodeur, and L. Brissette SR-BI, CD36, and caveolin-1 contribute positively to cholesterol efflux in hepatic cells Cell Biochem Funct 28 2010 480 489
82. P. Stralfors Caveolins and caveolae, roles in insulin signalling and diabetes Adv Exp Med Biol 729 2012 111 126
83. M. Mastrodonato, G. Calamita, R. Rossi, D. Mentino, L. Bonfrate, and P. Portincasa et al. Altered distribution of caveolin-1 in early liver steatosis Eur J Clin Invest 41 2011 642 651
84. J. Pohl, A. Ring, and W. Stremmel Uptake of long-chain fatty acids in HepG2 cells involves caveolae: analysis of a novel pathway J Lipid Res 43 2002 1390 1399
85. K.D. Corbin, and S.H. Zeisel Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression Curr Opin Gastroenterol 28 2012 159 165
86. P.J. Raubenheimer, M.J. Nyirenda, and B.R. Walker A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet Diabetes 55 2006 2015 2020 (Pubitemid 44509974)
87. E. Currie, A. Schulze, R. Zechner, T.C. Walther, and R.V. Farese Jr. Cellular fatty acid metabolism and cancer Cell Metab 18 2013 153 161
88. A.C. Calkin, and P. Tontonoz Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR Nat Rev Mol Cell Biol 13 2012 213 224
89. Line M. Grønning-Wang, Christian Bindesbøll, and Hilde I. Nebb The role of liver X receptor in hepatic de novo lipogenesis and cross-talk with insulin and glucose signaling Rodrigo Valenzuela Baez, Lipid metabolism 2013 InTech 60
90. N.Y. Kalaany, K.C. Gauthier, A.M. Zavacki, P.P. Mammen, T. Kitazume, and J.A. Peterson et al. LXRs regulate the balance between fat storage and oxidation Cell Metab 1 2005 231 244 (Pubitemid 43960607)
91. J. Beltowski Liver X receptors (LXR) as therapeutic targets in dyslipidemia Cardiovasc Ther 26 2008 297 316
92. C. Wilson Metabolism: LRH-1 is a transcriptional regulator of glucokinase in the liver Nat Rev Endocrinol 8 2012 566
93. M.H. Oosterveer, C. Mataki, H. Yamamoto, T. Harach, N. Moullan, and T.H. van Dijk et al. LRH-1-dependent glucose sensing determines intermediary metabolism in liver J Clin Invest 122 2012 2817 2826
94. K.E. Matsukuma, L. Wang, M.K. Bennett, and T.F. Osborne A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor J Biol Chem 282 2007 20164 20171 (Pubitemid 47099984)
95. S. Cipriani, A. Mencarelli, G. Palladino, and S. Fiorucci FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats J Lipid Res 51 2010 771 784
96. Y. Ma, Y. Huang, L. Yan, M. Gao, and D. Liu Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance Pharm Res 30 2013 1447 1457
97. J. Gao, and W. Xie Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism Drug Metab Dispos 38 2010 2091 2095
98. T. Wada, J. Gao, and W. Xie PXR and CAR in energy metabolism Trends Endocrinol Metab 20 2009 273 279
99. M. Durazzo, P. Belci, A. Collo, E. Grisoglio, and S. Bo Focus on therapeutic strategies of nonalcoholic fatty liver disease Int J Hepatol 2012 2012 464706
100. A. Tailleux, K. Wouters, and B. Staels Roles of PPARs in NAFLD: potential therapeutic targets Biochim Biophys Acta 1821 2012 809 818
101. Chih-Hao Lee, Peter Olson, Andrea Hevener, Isaac Mehl, Ling-Wa Chong, and Jerrold M. Olefsky et al. PPARδ regulates glucose metabolism and insulin sensitivity Proc Natl Acad Sci USA 103 2006 3444 3449 (Pubitemid 43346488)
102. J.M. Peters, I. Rusyn, M.L. Rose, F.J. Gonzalez, and R.G. Thurman Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis Carcinogenesis 21 2000 823 826 (Pubitemid 30214043)
103. L. Everett, A. Galli, and D. Crabb The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease Liver 20 2000 191 199 (Pubitemid 30342716)
104. K. Hellemans, L. Michalik, A. Dittie, A. Knorr, K. Rombouts, and J. De Jong et al. Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells Gastroenterology 124 2003 184 201 (Pubitemid 36055351)
105. S.R. Pyper, N. Viswakarma, S. Yu, and J.K. Reddy PPARalpha: energy combustion, hypolipidemia, inflammation and cancer Nucl Recept Signal 8 2010 e002
106. C.Z. Larter, M.M. Yeh, D.M. Van Rooyen, J. Brooling, K. Ghatora, and G.C. Farrell Peroxisome proliferator-activated receptor-alpha agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis J Gastroenterol Hepatol 27 2012 341 350
107. R. Stienstra, F. Saudale, C. Duval, S. Keshtkar, J.E. Groener, and N. van Rooijen et al. Kupffer cells promote hepatic steatosis via interleukin-1beta- dependent suppression of peroxisome proliferator-activated receptor alpha activity Hepatology 51 2010 511 522
108. M.A. Fernandez-Rojo, C. Restall, C. Ferguson, N. Martel, S. Martin, and M. Bosch et al. Caveolin-1 orchestrates the balance between glucose and lipid-dependent energy metabolism: implications for liver regeneration Hepatology 55 2012 1574 1584
109. O. Kimura, Y. Kondo, and T. Shimosegawa PPAR could contribute to the pathogenesis of hepatocellular carcinoma PPAR Res 2012 2012 574180
110. O. Braissant, F. Foufelle, C. Scotto, M. Dauca, and W. Wahli Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat Endocrinology 137 1996 354 366 (Pubitemid 26005011)
111. M. Peyrou, P. Ramadori, L. Bourgoin, and M. Foti PPARs in liver diseases and cancer: epigenetic regulation by microRNAs PPAR Res 2012 2012 757803
112. P.A. Grimaldi Metabolic and nonmetabolic regulatory functions of peroxisome proliferator-activated receptor beta Curr Opin Lipidol 21 2010 186 191
113. A.N. Billin PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home Expert Opin Invest Drug 17 2008 1465 1471
114. K. Iwaisako, M. Haimerl, Y.H. Paik, K. Taura, Y. Kodama, and C. Sirlin et al. Protection from liver fibrosis by a peroxisome proliferator-activated receptor delta agonist Proc Natl Acad Sci USA 109 2012 E1369 E1376
115. S. Hazra, S. Xiong, J. Wang, R.A. Rippe, V. Krishna, and K. Chatterjee et al. Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells J Biol Chem 279 2004 11392 11401 (Pubitemid 38401638)
116. A. Bonen, S.E. Campbell, C.R. Benton, A. Chabowski, S.L. Coort, and X.X. Han et al. Regulation of fatty acid transport by fatty acid translocase/CD36 Proc Nutr Soc 63 2004 245 249 (Pubitemid 38787473)
117. E. Moran-Salvador, M. Lopez-Parra, V. Garcia-Alonso, E. Titos, M. Martinez-Clemente, and A. Gonzalez-Periz et al. Role for PPARgamma in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts FASEB J 25 2011 2538 2550
118. B. Staels, A. Rubenstrunk, B. Noel, G. Rigou, P. Delataille, and L.J. Millatt et al. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis Hepatology 2013
119. A. Rogue, C. Spire, M. Brun, N. Claude, and A. Guillouzo Gene expression changes induced by PPAR gamma agonists in animal and human liver PPAR Res 2010 2010 325183
120. J. Yu, B. Shen, E.S. Chu, N. Teoh, K.F. Cheung, and C.W. Wu et al. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro Hepatology 51 2010 2008 2019
121. K. Uchimura, M. Nakamuta, M. Enjoji, T. Irie, R. Sugimoto, and T. Muta et al. Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells Hepatology 33 2001 91 99 (Pubitemid 32016891)
122. E. Sharvit, S. Abramovitch, S. Reif, and R. Bruck Amplified inhibition of stellate cell activation pathways by PPAR-gamma, RAR and RXR agonists PLoS One 8 2013 e76541
123. H. Schrem, J. Klempnauer, and J. Borlak Liver-enriched transcription factors in liver function and development. Part II: The C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation Pharmacol Rev 56 2004 291 330 (Pubitemid 38720832)
124. K. Sekine, Y.R. Chen, N. Kojima, K. Ogata, A. Fukamizu, and A. Miyajima Foxo1 links insulin signaling to C/EBPalpha and regulates gluconeogenesis during liver development EMBO J 26 2007 3607 3615 (Pubitemid 47236870)
125. Y. Inoue, J. Inoue, G. Lambert, S.H. Yim, and F.J. Gonzalez Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosis J Biol Chem 279 2004 44740 44748 (Pubitemid 39430884)
126. J. Jin, P. Iakova, M. Breaux, E. Sullivan, N. Jawanmardi, and D. Chen et al. Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis Cell Rep 3 2013 831 843
127. S.M. Rahman, J.M. Schroeder-Gloeckler, R.C. Janssen, H. Jiang, I. Qadri, and K.N. Maclean et al. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis Hepatology 45 2007 1108 1117 (Pubitemid 46775772)
128. H. Schrem, J. Klempnauer, and J. Borlak Liver-enriched transcription factors in liver function and development. Part I: The hepatocyte nuclear factor network and liver-specific gene expression Pharmacol Rev 54 2002 129 158 (Pubitemid 34208830)
129. X. Xie, H. Liao, H. Dang, W. Pang, Y. Guan, and X. Wang et al. Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs Mol Endocrinol 23 2009 434 443
130. S. Zuniga, D. Firrincieli, C. Housset, and N. Chignard Vitamin D and the vitamin D receptor in liver pathophysiology Clin Res Hepatol Gastroenterol 35 2011 295 302
131. B.W. Smith, and L.A. Adams Non-alcoholic fatty liver disease Crit Rev Clin Lab Sci 48 2011 97 113
132. E.E. Cable, P.D. Finn, J.W. Stebbins, J. Hou, B.R. Ito, and P.D. van Poelje et al. Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist Hepatology 49 2009 407 417
133. B.A. Neuschwander-Tetri Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASH Curr Gastroenterol Rep 12 2010 49 56
134. P.D. Denechaud, R. Dentin, J. Girard, and C. Postic Role of ChREBP in hepatic steatosis and insulin resistance FEBS Lett 582 2008 68 73 (Pubitemid 350297238)
135. F. Benhamed, P.D. Denechaud, M. Lemoine, C. Robichon, M. Moldes, and J. Bertrand-Michel et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans J Clin Invest 122 2012 2176 2194
136. G. Filhoulaud, S. Guilmeau, R. Dentin, J. Girard, and C. Postic Novel insights into ChREBP regulation and function Trends Endocrinol Metab 24 2013 257 268
137. J.L. Owen, Y. Zhang, S.H. Bae, M.S. Farooqi, G. Liang, and R.E. Hammer et al. Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase Proc Natl Acad Sci USA 109 2012 16184 16189
138. P. Ferre, and F. Foufelle Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c Diabetes Obes Metab 12 Suppl 2 2010 83 92
139. J.L. Yecies, H.H. Zhang, S. Menon, S. Liu, D. Yecies, and A.I. Lipovsky et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways Cell Metab 14 2011 21 32
140. I. Bakan, and M. Laplante Connecting mTORC1 signaling to SREBP-1 activation Curr Opin Lipidol 23 2012 226 234
141. X. Guo, H. Li, H. Xu, V. Halim, W. Zhang, and H. Wang et al. Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice PLoS One 7 2012 e39286
142. S. Turro, M. Ingelmo-Torres, J.M. Estanyol, F. Tebar, M.A. Fernandez, and C.V. Albor et al. Identification and characterization of associated with lipid droplet protein 1: a novel membrane-associated protein that resides on hepatic lipid droplets Traffic 7 2006 1254 1269 (Pubitemid 44204000)
143. K. Rasineni, B.L. McVicker, D.J. Tuma, M.A. McNiven, and C.A. Casey Rab GTPases associate with isolated lipid droplets (LDs) and show altered content after ethanol administration: potential role in alcohol-impaired LD metabolism Alcohol Clin Exp Res 2013
144. H. Li, Y. Song, L.J. Zhang, Y. Gu, F.F. Li, and S.Y. Pan et al. LSDP5 enhances triglyceride storage in hepatocytes by influencing lipolysis and fatty acid beta-oxidation of lipid droplets PLoS One 7 2012 e36712
145. L. Yang, Y. Ding, Y. Chen, S. Zhang, C. Huo, and Y. Wang et al. The proteomics of lipid droplets: structure, dynamics, and functions of the organelle conserved from bacteria to humans J Lipid Res 53 2012 1245 1253
146. M. Suzuki, Y. Shinohara, Y. Ohsaki, and T. Fujimoto Lipid droplets: size matters J Electron Microsc (Tokyo) 60 Suppl 1 2011 S101 S116
147. R. Bartz, W.H. Li, B. Venables, J.K. Zehmer, M.R. Roth, and R. Welti et al. Lipidomics reveals that adiposomes store ether lipids and mediate phospholipid traffic J Lipid Res 48 2007 837 847 (Pubitemid 46557888)
148. K. Tauchi-Sato, S. Ozeki, T. Houjou, R. Taguchi, and T. Fujimoto The surface of lipid droplets is a phospholipid monolayer with a unique fatty acid composition J Biol Chem 277 2002 44507 44512 (Pubitemid 36157885)
149. D.A. Brown Lipid droplets: proteins floating on a pool of fat Curr Biol 11 2001 R446 R449
150. K.M. Szymanski, D. Binns, R. Bartz, N.V. Grishin, W.P. Li, and A.K. Agarwal et al. The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology Proc Natl Acad Sci USA 104 2007 20890 20895
151. D. Binns, S. Lee, C.L. Hilton, Q.X. Jiang, and J.M. Goodman Seipin is a discrete homooligomer Biochemistry 49 2010 10747 10755
152. W. Fei, H. Li, G. Shui, T.S. Kapterian, C. Bielby, and X. Du et al. Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis J Lipid Res 52 2011 2136 2147
153. W. Fei, G. Shui, B. Gaeta, X. Du, L. Kuerschner, and P. Li et al. Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast J Cell Biol 180 2008 473 482 (Pubitemid 351240697)
154. Y. Tian, J. Bi, G. Shui, Z. Liu, Y. Xiang, and Y. Liu et al. Tissue-autonomous function of Drosophila seipin in preventing ectopic lipid droplet formation PLoS Genet 7 2011 e1001364
155. H.L. Ploegh A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum Nature 448 2007 435 438 (Pubitemid 47123517)
156. Y. Guo, K.R. Cordes, R.V. Farese Jr, and T.C. Walther Lipid droplets at a glance J Cell Sci 122 2009 749 752
157. T.C. Walther, and R.V. Farese Jr. The life of lipid droplets Biochim Biophys Acta 1791 2009 459 466
158. D.L. Brasaemle, V. Subramanian, A. Garcia, A. Marcinkiewicz, and A. Rothenberg Perilipin A and the control of triacylglycerol metabolism Mol Cell Biochem 326 2009 15 21
159. C.E. Smith, and J.M. Ordovas Update on perilipin polymorphisms and obesity Nutr Rev 70 2012 611 621
160. H. Wang, U. Sreenevasan, H. Hu, A. Saladino, B.M. Polster, and L.M. Lund et al. Perilipin 5, a lipid droplet-associated protein, provides physical and
161. A.R. Kimmel, D.L. Brasaemle, M. McAndrews-Hill, C. Sztalryd, and C. Londos Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins J Lipid Res 51 2010 468 471
162. X. Li, J. Ye, L. Zhou, W. Gu, E.A. Fisher, and P. Li Opposing roles of cell death-inducing DFF45-like effector B and perilipin 2 in controlling hepatic VLDL lipidation J Lipid Res 53 2012 1877 1889
163. W. Motomura, M. Inoue, T. Ohtake, N. Takahashi, M. Nagamine, and S. Tanno et al. Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet Biochem Biophys Res Commun 340 2006 1111 1118 (Pubitemid 43083393)
164. Y. Imai, S. Boyle, G.M. Varela, E. Caron, X. Yin, and R. Dhir et al. Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression Physiol Genomics 44 2012 1125 1131
165. R.M. Carr, R.T. Patel, V. Rao, R. Dhir, M.J. Graham, and R.M. Crooke et al. Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice Am J Physiol Regul Integr Comp Physiol 302 2012 R996 R1003
166. S. Martin, K. Driessen, S.J. Nixon, M. Zerial, and R.G. Parton Regulated localization of Rab18 to lipid droplets: effects of lipolytic stimulation and inhibition of lipid droplet catabolism J Biol Chem 280 2005 42325 42335 (Pubitemid 43023204)
167. J.M. Goodman The gregarious lipid droplet J Biol Chem 283 2008 28005 28009
168. M.R. Pulido, A. Diaz-Ruiz, Y. Jimenez-Gomez, S. Garcia-Navarro, F. Gracia-Navarro, and F. Tinahones et al. Rab18 dynamics in adipocytes in relation to lipogenesis, lipolysis and obesity PLoS One 6 2011 e22931
169. S. Ozeki, J. Cheng, K. Tauchi-Sato, N. Hatano, H. Taniguchi, and T. Fujimoto Rab18 localizes to lipid droplets and induces their close apposition to the endoplasmic reticulum-derived membrane J Cell Sci 118 2005 2601 2611 (Pubitemid 40932886)
170. A.M. van der Bliek A sixth sense for Rab5 Nat Cell Biol 7 2005 548 550
171. P. Liu, R. Bartz, J.K. Zehmer, Y.S. Ying, M. Zhu, and G. Serrero et al. Rab-regulated interaction of early endosomes with lipid droplets Biochim Biophys Acta 1773 2007 784 793 (Pubitemid 46829428)
172. C. Wang, Z. Liu, and X. Huang Rab32 is important for autophagy and lipid storage in Drosophila PLoS One 7 2012 e32086
173. V. Puri Fasting regulates FSP27 expression in the liver J Lipid Res 54 2013 569 570
174. A. Vila-Brau, A.L. De Sousa-Coelho, J.F. Goncalves, D. Haro, and P.F. Marrero Fsp27/CIDEC is a CREB target gene induced during early fasting in liver and regulated by FA oxidation rate J Lipid Res 54 2013 592 601
175. T. Gimm, M. Wiese, B. Teschemacher, A. Deggerich, J. Schodel, and K.X. Knaup et al. Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1 FASEB J 24 2010 4443 4458
176. C.D. Byrne Hypoxia and non-alcoholic fatty liver disease Clin Sci (Lond) 118 2009 397 400
177. T. Nitta, J.S. Kim, D. Mohuczy, and K.E. Behrns Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways Hepatology 48 2008 909 919
178. S.J. Lee, S.Y. Choi, and O.S. Kwon The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis BMB Rep 2013
179. X. Cui, Y. Wang, Y. Tang, Y. Liu, L. Zhao, and J. Deng et al. Seipin ablation in mice results in severe generalized lipodystrophy Hum Mol Genet 20 2011 3022 3030
180. B. Kadereit, P. Kumar, W.J. Wang, D. Miranda, E.L. Snapp, and N. Severina et al. Evolutionarily conserved gene family important for fat storage Proc Natl Acad Sci USA 105 2008 94 99
181. B.N. Finck, M.C. Gropler, Z. Chen, T.C. Leone, M.A. Croce, and T.E. Harris et al. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway Cell Metab 4 2006 199 210 (Pubitemid 44283957)
182. W. Yang, S. Thein, X. Guo, F. Xu, B. Venkatesh, and S. Sugii et al. Seipin differentially regulates lipogenesis and adipogenesis through a conserved core sequence and an evolutionarily acquired C-terminus Biochem J 452 2013 37 44
183. D.A. Gross, C. Zhan, and D.L. Silver Direct binding of triglyceride to fat storage-inducing transmembrane proteins 1 and 2 is important for lipid droplet formation Proc Natl Acad Sci USA 108 2011 19581 19586
184. D.A. Gross, E.L. Snapp, and D.L. Silver Structural insights into triglyceride storage mediated by fat storage-inducing transmembrane (FIT) protein 2 PLoS One 5 2010 e10796
185. D.T. Browman, M.B. Hoegg, and S.M. Robbins The SPFH domain-containing proteins: more than lipid raft markers Trends Cell Biol 17 2007 394 402 (Pubitemid 47375100)
186. L.J. Pike The challenge of lipid rafts J Lipid Res 50 Suppl 2009 S323 S328
187. L. Rajendran, S. Le Lay, and H. Illges Raft association and lipid droplet targeting of flotillins are independent of caveolin Biol Chem 388 2007 307 314 (Pubitemid 46364470)
188. Kelly K, Jacobs RL. Phospholpid biosynthesis. The AOCS Lipid Library [Internet]; 2011. < http://lipidlibrary.aocs.org/animbio/phospholipids/index. htm > [cited 19.11.2013].
189. V. Haucke, and G. Di Paolo Lipids and lipid modifications in the regulation of membrane traffic Curr Opin Cell Biol 19 2007 426 435 (Pubitemid 47268765)
190. A. Pol, S. Martin, M.A. Fernandez, C. Ferguson, A. Carozzi, and R. Luetterforst et al. Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant Mol Biol Cell 15 2004 99 110 (Pubitemid 38044947)
191. M.A. McNiven, and C.A. Casey Alcohol and lipid traffic don't mix Hepatology 53 2011 1073 1075
192. L. Cubells, S. Vila de Muga, F. Tebar, P. Wood, R. Evans, and M. Ingelmo-Torres et al. Annexin A6-induced alterations in cholesterol transport and caveolin export from the Golgi complex Traffic 8 2007 1568 1589 (Pubitemid 47578362)
193. N. Xu, S.O. Zhang, R.A. Cole, S.A. McKinney, F. Guo, and J.T. Haas et al. The FATP1-DGAT2 complex facilitates lipid droplet expansion at the ER-lipid droplet interface J Cell Biol 198 2012 895 911
194. H.R. Wurie, L. Buckett, and V.A. Zammit Evidence that diacylglycerol acyltransferase 1 (DGAT1) has dual membrane topology in the endoplasmic reticulum of HepG2 cells J Biol Chem 286 2011 36238 36247
195. D.F. Markgraf, R.W. Klemm, M. Junker, H.K. Hannibal-Bach, C.S. Ejsing, and T.A. Rapoport An ER protein functionally couples neutral lipid metabolism on lipid droplets to membrane lipid synthesis in the ER Cell Rep 6 2014 44 55
196. J.A. Olzmann, C.M. Richter, and R.R. Kopito Spatial regulation of UBXD8 and p97/VCP controls ATGL-mediated lipid droplet turnover Proc Natl Acad Sci USA 110 2013 1345 1350
197. K.G. Soni, G.A. Mardones, R. Sougrat, E. Smirnova, C.L. Jackson, and J.S. Bonifacino Coatomer-dependent protein delivery to lipid droplets J Cell Sci 122 2009 1834 1841
198. C. Zhang, G. Wang, Z. Zheng, K.R. Maddipati, X. Zhang, and G. Dyson et al. Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice Hepatology 55 2012 1070 1082
199. J. Tsai, W. Qiu, R. Kohen-Avramoglu, and K. Adeli MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly Arterioscler Thromb Vasc Biol 27 2007 211 218 (Pubitemid 46360401)
200. J.D. Sparks, C.E. Sparks, and K. Adeli Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia Arterioscler Thromb Vasc Biol 32 2012 2104 2112
201. H. Wang, E. Wei, A.D. Quiroga, X. Sun, N. Touret, and R. Lehner Altered lipid droplet dynamics in hepatocytes lacking triacylglycerol hydrolase expression Mol Biol Cell 21 2010 1991 2000
202. U. Andreo, L. Guo, D.V. Chirieac, A.C. Tuyama, E. Montenont, and J.L. Brodsky et al. Insulin-stimulated degradation of apolipoprotein B100: roles of class II phosphatidylinositol-3-kinase and autophagy PLoS One 8 2013 e57590
203. T. Ota, C. Gayet, and H.N. Ginsberg Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents J Clin Invest 118 2008 316 332
204. H. Jo, S.S. Choe, K.C. Shin, H. Jang, J.H. Lee, and J.K. Seong et al. Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor Hepatology 57 2013 1366 1377
205. F. Wilfling, H. Wang, J.T. Haas, N. Krahmer, T.J. Gould, and A. Uchida et al. Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets Dev Cell 24 2013 384 399
206. K. Matsusue, T. Kusakabe, T. Noguchi, S. Takiguchi, T. Suzuki, and S. Yamano et al. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27 Cell Metab 7 2008 302 311 (Pubitemid 351455219)
207. S.O. Olofsson, P. Bostrom, J. Lagerstedt, L. Andersson, M. Adiels, and J. Perman et al. The lipid droplet: a dynamic organelle, not only involved in the storage and turnover of lipids C. Ehnholm, Cellular lipid metabolism 2009 Springer-Verlag Berlin, Heidelberg 1 26
208. P. Bostrom, L. Andersson, M. Rutberg, J. Perman, U. Lidberg, and B.R. Johansson et al. SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity Nat Cell Biol 9 2007 1286 1293 (Pubitemid 350042360)
209. T. Ohya, M. Miaczynska, U. Coskun, B. Lommer, A. Runge, and D. Drechsel et al. Reconstitution of Rab- and SNARE-dependent membrane fusion by synthetic endosomes Nature 459 2009 1091 1097
210. P. Bostrom, M. Rutberg, J. Ericsson, P. Holmdahl, L. Andersson, and M.A. Frohman et al. Cytosolic lipid droplets increase in size by microtubule- dependent complex formation Arterioscler Thromb Vasc Biol 25 2005 1945 1951 (Pubitemid 41243467)
211. S.O. Olofsson, L. Andersson, L. Haversen, C. Olsson, S. Myhre, and M. Rutberg et al. The formation of lipid droplets: possible role in the development of insulin resistance/type 2 diabetes Prostaglandins Leukot Essent Fatty Acids 85 2011 215 218
212. J.W. Wu, S.P. Wang, F. Alvarez, S. Casavant, N. Gauthier, and L. Abed et al. Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis Hepatology 54 2011 122 132
213. K.T. Ong, M.T. Mashek, S.Y. Bu, and D.G. Mashek Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation FASEB J 27 2013 313 321
214. J.L. Cantley, T. Yoshimura, J.P. Camporez, D. Zhang, F.R. Jornayvaz, and N. Kumashiro et al. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance Proc Natl Acad Sci USA 110 2013 1869 1874
215. J.N. Lee, H. Kim, H. Yao, Y. Chen, K. Weng, and J. Ye Identification of Ubxd8 protein as a sensor for unsaturated fatty acids and regulator of triglyceride synthesis Proc Natl Acad Sci USA 107 2010 21424 21429
216. Y. Ohsaki, J. Cheng, A. Fujita, T. Tokumoto, and T. Fujimoto Cytoplasmic lipid droplets are sites of convergence of proteasomal and autophagic degradation of apolipoprotein B Mol Biol Cell 17 2006 2674 2683 (Pubitemid 43825504)
217. P.C. Kienesberger, M. Oberer, A. Lass, and R. Zechner Mammalian patatin domain containing proteins: a family with diverse lipolytic activities involved in multiple biological functions J Lipid Res 50 Suppl 2009 S63 S68
218. W. Chen, B. Chang, L. Li, and L. Chan Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease Hepatology 52 2010 1134 1142
219. M.K. Basantani, M.T. Sitnick, L. Cai, D.S. Brenner, N.P. Gardner, and J.Z. Li et al. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome J Lipid Res 52 2011 318 329
220. A. Bartelt, P. Orlando, C. Mele, A. Ligresti, K. Toedter, and L. Scheja et al. Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance Diabetologia 54 2011 2900 2910
221. R. Singh, and A.M. Cuervo Lipophagy: connecting autophagy and lipid metabolism Int J Cell Biol 2012 2012 282041
222. K. Liu, and M.J. Czaja Regulation of lipid stores and metabolism by lipophagy Cell Death Differ 20 2013 3 11
223. P. Christian, J. Sacco, and K. Adeli Autophagy: emerging roles in lipid homeostasis and metabolic control Biochim Biophys Acta 1831 2013 819 824
224. C. Carter-Kent, N.N. Zein, and A.E. Feldstein Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment Am J Gastroenterol 103 2008 1036 1042 (Pubitemid 351501089)
225. Y. Inami, S. Yamashina, K. Izumi, T. Ueno, I. Tanida, and K. Ikejima et al. Hepatic steatosis inhibits autophagic proteolysis via impairment of autophagosomal acidification and cathepsin expression Biochem Biophys Res Commun 412 2011 618 625
226. Q. Feng, Y. Cheng, Y.Y. Hu, H. Zhang, J.H. Peng, and N. Zhang Qushi Huayu Decoction (QHD) inhibits protein and gene expression of cathepsin B in HepG2 cells induced by free fatty acids Chin J Integr Med 16 2010 518 524
227. M. Shibata, K. Yoshimura, N. Furuya, M. Koike, T. Ueno, and M. Komatsu et al. The MAP1-LC3 conjugation system is involved in lipid droplet formation Biochem Biophys Res Commun 382 2009 419 423
228. R. Bartz, J.K. Zehmer, M. Zhu, Y. Chen, G. Serrero, and Y. Zhao et al. Dynamic activity of lipid droplets: protein phosphorylation and GTP-mediated protein translocation J Proteome Res 6 2007 3256 3265 (Pubitemid 47310210)
229. M. Beller, K. Thiel, P.J. Thul, and H. Jackle Lipid droplets: a dynamic organelle moves into focus FEBS Lett 584 2010 2176 2182
230. C. D'Souza-Schorey, and P. Chavrier ARF proteins: roles in membrane traffic and beyond Nat Rev Mol Cell Biol 7 2006 347 358
231. S. Murphy, S. Martin, and R.G. Parton Lipid droplet-organelle interactions; sharing the fats Biochim Biophys Acta 1791 2009 441 447
232. A. Zeigerer, J. Gilleron, R.L. Bogorad, G. Marsico, H. Nonaka, and S. Seifert et al. Rab5 is necessary for the biogenesis of the endolysosomal system in vivo Nature 485 2012 465 470
233. M. Zhang, L. Chen, S. Wang, and T. Wang Rab7: roles in membrane trafficking and disease Biosci Rep 29 2009 193 209
234. C. Yeaman, M.I. Ayala, J.R. Wright, F. Bard, C. Bossard, and A. Ang et al. Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network Nat Cell Biol 6 2004 106 112 (Pubitemid 38425709)
235. O.O. Glebov, N.A. Bright, and B.J. Nichols Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells Nat Cell Biol 8 2006 46 54 (Pubitemid 43064796)
236. M.A. Tarnopolsky, C.D. Rennie, H.A. Robertshaw, S.N. Fedak-Tarnopolsky, M.C. Devries, and M.J. Hamadeh Influence of endurance exercise training and sex on intramyocellular lipid and mitochondrial ultrastructure, substrate use, and mitochondrial enzyme activity Am J Physiol Regul Integr Comp Physiol 292 2007 R1271 R1278
237. Y. Ohba, T. Sakuragi, E. Kage-Nakadai, N.H. Tomioka, N. Kono, and R. Imae et al. Mitochondria-type GPAT is required for mitochondrial fusion EMBO J 32 2013 1265 1279
238. S.J. Stone, M.C. Levin, P. Zhou, J. Han, T.C. Walther, and R.V. Farese Jr. The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria J Biol Chem 284 2009 5352 5361
239. J.K. Zehmer, Y. Huang, G. Peng, J. Pu, R.G. Anderson, and P. Liu A role for lipid droplets in inter-membrane lipid traffic Proteomics 9 2009 914 921
240. A.W. Cohen, B. Razani, W. Schubert, T.M. Williams, X.B. Wang, and P. Iyengar et al. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation Diabetes 53 2004 1261 1270 (Pubitemid 38569012)
241. H.R. Waterham, and M.S. Ebberink Genetics and molecular basis of human peroxisome biogenesis disorders Biochim Biophys Acta 1822 2012 1430 1441
242. A.B. Novikoff, P.M. Novikoff, O.M. Rosen, and C.S. Rubin Organelle relationships in cultured 3T3-L1 preadipocytes J Cell Biol 87 1980 180 196
243. E.J. Blanchette-Mackie, N.K. Dwyer, T. Barber, R.A. Coxey, T. Takeda, and C.M. Rondinone et al. Perilipin is located on the surface layer of intracellular lipid droplets in adipocytes J Lipid Res 36 1995 1211 1226
244. S. Senthivinayagam, A.L. McIntosh, K.C. Moon, and B.P. Atshaves Plin2 inhibits cellular glucose uptake through interactions with SNAP23, a SNARE complex protein PLoS One 8 2013 e73696
245. T.H. Sollner Lipid droplets highjack SNAREs Nat Cell Biol 9 2007 1219 1220 (Pubitemid 350042349)
246. X. Wu, K. Chen, and K.J. Williams The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia Curr Opin Lipidol 23 2012 334 344
247. C. de Luca, and J.M. Olefsky Inflammation and insulin resistance FEBS Lett 582 2008 97 105 (Pubitemid 50010731)
248. A.S. Greenberg, R.A. Coleman, F.B. Kraemer, J.L. McManaman, M.S. Obin, and V. Puri et al. The role of lipid droplets in metabolic disease in rodents and humans J Clin Invest 121 2011 2102 2110
249. N. Kumashiro, D.M. Erion, D. Zhang, M. Kahn, S.A. Beddow, and X. Chu et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease Proc Natl Acad Sci USA 108 2011 16381 16385
250. A.M. Miller, H. Wang, A. Bertola, O. Park, N. Horiguchi, and S.H. Ki et al. Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice Hepatology 54 2011 846 856
251. K.J. Stanya, D. Jacobi, S. Liu, P. Bhargava, L. Dai, and M.R. Gangl et al. Direct control of hepatic glucose production by interleukin-13 in mice J Clin Invest 123 2013 261 271
252. M.J. Pagliassotti Endoplasmic reticulum stress in nonalcoholic fatty liver disease Annu Rev Nutr 32 2012 17 33
253. M. Vinciguerra, C. Veyrat-Durebex, M.A. Moukil, L. Rubbia-Brandt, F. Rohner-Jeanrenaud, and M. Foti PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTOR-dependent mechanism Gastroenterology 134 2008 268 280 (Pubitemid 350309315)
254. K. Zhang, X. Shen, J. Wu, K. Sakaki, T. Saunders, and D.T. Rutkowski et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response Cell 124 2006 587 599 (Pubitemid 43199443)
255. M. Monetti, M.C. Levin, M.J. Watt, B.K. Hubbard, C. Newgard, and R.V.S. Farese et al. Hepatic acyl-CoA:diacylglcyerol acyltransferase (DGAT) overexpression, diacylglycerol, and insulin sensitivity Proc Natl Acad Sci USA 108 2011 E523 [author reply E524]
256. F.R. Jornayvaz, A.L. Birkenfeld, M.J. Jurczak, S. Kanda, B.A. Guigni, and D.C. Jiang et al. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2 Proc Natl Acad Sci USA 108 2011 5748 5752
257. T. Arai, H.J. Kim, S. Hirako, M. Nakasatomi, H. Chiba, and A. Matsumoto Effects of dietary fat energy restriction and fish oil feeding on hepatic metabolic abnormalities and insulin resistance in KK mice with high-fat diet-induced obesity J Nutr Biochem 24 2013 267 273
258. P. Dobrzyn, and A. Dobrzyn Stearoyl-CoA desaturase: a new therapeutic target of liver steatosis Drug Dev Res 67 2006 643
259. B. Emanuelli, Y. Macotela, J. Boucher, and C. Ronald Kahn SOCS-1 deficiency does not prevent diet-induced insulin resistance Biochem Biophys Res Commun 377 2008 447 452
260. N. Sachithanandan, B.C. Fam, S. Fynch, N. Dzamko, M.J. Watt, and S. Wormald et al. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity Hepatology 52 2010 1632 1642
261. F. Zadjali, R. Santana-Farre, M. Vesterlund, B. Carow, M. Mirecki-Garrido, and I. Hernandez-Hernandez et al. SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice FASEB J 26 2012 3282 3291
262. I. Locatelli, S. Sutti, M. Vacchiano, C. Bozzola, and E. Albano NF-kappaB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses Clin Sci (Lond) 124 2013 279 287
263. U. Jaeger Drug sensitivity and sphingolipid metabolism in CLL Blood 120 2012 3865 3866
264. E. Arrojo, R. Drigo, and A.C. Bianco Type 2 deiodinase at the crossroads of thyroid hormone action Int J Biochem Cell Biol 43 2011 1432 1441
265. K. Matsusue Novel mechanism for hepatic lipid accumulation: a physiological role for hepatic PPARgamma-fsp27 signal Yakugaku Zasshi 132 2012 823 829
266. P. Liu, Y. Ying, Y. Zhao, D.I. Mundy, M. Zhu, and R.G. Anderson Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic J Biol Chem 279 2004 3787 3792 (Pubitemid 38140623)
267. A.J. Sanyal, N. Chalasani, K.V. Kowdley, A. McCullough, A.M. Diehl, and N.M. Bass et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
268. D. Berry, J.K. Wathen, and M. Newell Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality Clin Trials 6 2009 28 41
269. C.O. Zein, L.M. Yerian, P. Gogate, R. Lopez, J.P. Kirwan, and A.E. Feldstein et al. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial Hepatology 54 2011 1610 1619
270. C.O. Zein, R. Lopez, X. Fu, J.P. Kirwan, L.M. Yerian, and A.J. McCullough et al. Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism Hepatology 56 2012 1291 1299
271. P. Paschos, and K. Tziomalos Nonalcoholic fatty liver disease and the renin-angiotensin system: implications for treatment World J Hepatol 4 2012 327 331
272. M.S. Kostapanos, E.C. Rizos, N. Papanas, E. Maltezos, and M.S. Elisaf Mitochondrial triglyceride transfer protein inhibition: new achievements in the treatment of dyslipidemias Curr Pharm Des 19 2013 3150 3160
273. B. Sun, and M. Karin Obesity, inflammation, and liver cancer J Hepatol 56 2012 704 713
274. S.L. Deshmane, S. Kremlev, S. Amini, and B.E. Sawaya Monocyte chemoattractant protein-1 (MCP-1): an overview J Interferon Cytokine Res 29 2009 313 326
275. H.W. Zimmermann, C. Trautwein, and F. Tacke Functional role of monocytes and macrophages for the inflammatory response in acute liver injury Front Physiol 3 2012 56
276. K. Miura, L. Yang, N. van Rooijen, H. Ohnishi, and E. Seki Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2 Am J Physiol Gastrointest Liver Physiol 302 2012 G1310 G1321
277. H. Kanda, S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, and R. Kitazawa et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity J Clin Invest 116 2006 1494 1505
278. E. Seki, D.A. Brenner, and M. Karin A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches Gastroenterology 143 2012 307 320
279. Y. Nakayama, R. Komuro, A. Yamamoto, Y. Miyata, M. Tanaka, and M. Matsuda et al. RhoA induces expression of inflammatory cytokine in adipocytes Biochem Biophys Res Commun 379 2009 288 292
280. S. Tada, H. Iwamoto, M. Nakamuta, R. Sugimoto, M. Enjoji, and Y. Nakashima et al. A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats J Hepatol 34 2001 529 536 (Pubitemid 32328509)
281. L. Zhao, Y. Chen, R. Tang, Y. Chen, Q. Li, and J. Gong et al. Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis J Gastroenterol Hepatol 26 2011 875 883
282. Y. Chen, Y. Chen, L. Zhao, Y. Chen, M. Mei, and Q. Li et al. Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export J Gastroenterol Hepatol 27 2012 974 984
283. V. Bieghs, P.J. Van Gorp, K. Wouters, T. Hendrikx, M.J. Gijbels, and M. van Bilsen et al. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease PLoS One 7 2012 e30668
284. F. Rangwala, C.D. Guy, J. Lu, A. Suzuki, J.L. Burchette, and M.F. Abdelmalek et al. Increased production of sonic hedgehog by ballooned hepatocytes J Pathol 224 2011 401 410
285. A. Omenetti, S. Choi, G. Michelotti, and A.M. Diehl Hedgehog signaling in the liver J Hepatol 54 2011 366 373
286. A. Pratap, S. Singh, V. Mundra, N. Yang, R. Panakanti, and J.D. Eason et al. Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling J Drug Target 20 2012 770 782
287. R.S. McCuskey, Y. Ito, G.R. Robertson, M.K. McCuskey, M. Perry, and G.C. Farrell Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice Hepatology 40 2004 386 393 (Pubitemid 39062856)
288. J. Chang, T. Hisamatsu, K. Shimamura, K. Yoneno, M. Adachi, and H. Naruse et al. Activated hepatic stellate cells mediate the differentiation of macrophages Hepatol Res 43 2013 658 669
289. K. Iwamoto, K. Kanno, H. Hyogo, S. Yamagishi, M. Takeuchi, and S. Tazuma et al. Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells J Gastroenterol 43 2008 298 304 (Pubitemid 351650040)
290. K. Ohashi, H.K. Takahashi, S. Mori, K. Liu, H. Wake, and H. Sadamori et al. Advanced glycation end products enhance monocyte activation during human mixed lymphocyte reaction Clin Immunol 134 2010 345 353
291. C. Baeck, A. Wehr, K.R. Karlmark, F. Heymann, M. Vucur, and N. Gassler et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury Gut 61 2012 416 426
292. M. Pasarin, J.G. Abraldes, A. Rodriguez-Vilarrupla, V. La Mura, J.C. Garcia-Pagan, and J. Bosch Insulin resistance and liver microcirculation in a rat model of early NAFLD J Hepatol 55 2011 1095 1102
293. S. Ijaz, M.C. Winslet, and A.M. Seifalian The effect of consecutively larger doses of l-arginine on hepatic microcirculation and tissue oxygenation in hepatic steatosis Microvasc Res 78 2009 206 211
294. G.C. Farrell, N.C. Teoh, and R.S. McCuskey Hepatic microcirculation in fatty liver disease Anat Rec (Hoboken) 291 2008 684 692
295. S. Rosenstengel, S. Stoeppeler, R. Bahde, H.U. Spiegel, and D. Palmes Type of steatosis influences microcirculation and fibrogenesis in different rat strains J Invest Surg 24 2011 273 282
296. G. Baffy Kupffer cells in non-alcoholic fatty liver disease: the emerging view J Hepatol 51 2009 212 223
297. A.C. Tosello-Trampont, S.G. Landes, V. Nguyen, T.I. Novobrantseva, and Y.S. Hahn Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production J Biol Chem 287 2012 40161 40172
298. W. Huang, A. Metlakunta, N. Dedousis, P. Zhang, I. Sipula, and J.J. Dube et al. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance Diabetes 59 2010 347 357
299. J. O'Connell, L. Lynch, T.J. Cawood, A. Kwasnik, N. Nolan, and J. Geoghegan et al. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity PLoS One 5 2010 e9997
300. C. Hurtado del Pozo, G. Vesperinas-Garcia, M.A. Rubio, R. Corripio-Sanchez, A.J. Torres-Garcia, and M.J. Obregon et al. ChREBP expression in the liver, adipose tissue and differentiated preadipocytes in human obesity Biochim Biophys Acta 1811 2011 1194 1200
301. C. Guinez, G. Filhoulaud, F. Rayah-Benhamed, S. Marmier, C. Dubuquoy, and R. Dentin et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver Diabetes 60 2011 1399 1413
302. T. Ueno, A. Nakamura, H. Nakayama, S. Otabe, X. Yuan, and T. Fukutani et al. Adiponectin suppresses endoplasmic reticulum stress in nonalcoholic steatohepatitis Exp Ther Med 2 2011 1035 1040
303. A.R. Moschen, V. Wieser, and H. Tilg Adiponectin: key player in the adipose tissue-liver crosstalk Curr Med Chem 19 2012 5467 5473
304. X.G. Hou, S. Moser, M.G. Sarr, G.B. Thompson, F.G. Que, and M.D. Jensen Visceral and subcutaneous adipose tissue diacylglycerol acyltransferase activity in humans Obesity (Silver Spring) 17 2009 1129 1134
305. C.A. Harris, J.T. Haas, R.S. Streeper, S.J. Stone, M. Kumari, and K. Yang et al. DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes J Lipid Res 52 2011 657 667
306. A.M. Diehl, Z.P. Li, H.Z. Lin, and S.Q. Yang Cytokines and the pathogenesis of non-alcoholic steatohepatitis Gut 54 2005 303 306 (Pubitemid 40139250)
307. S.E. Regnell, and A. Lernmark Hepatic steatosis in type 1 diabetes Rev Diabet Stud 8 2011 454 467
308. S. Wang, A. Kamat, P. Pergola, A. Swamy, F. Tio, and K. Cusi Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo Metabolism 60 2011 1090 1099
309. H.A. Jamieson, V.C. Cogger, S.M. Twigg, S.V. McLennan, A. Warren, and R. Cheluvappa et al. Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetes Diabetologia 50 2007 1969 1976 (Pubitemid 47222858)
310. V. Kus, P. Flachs, O. Kuda, K. Bardova, P. Janovska, and M. Svobodova et al. Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet PLoS One 6 2011 e27126
311. E. Boettcher, G. Csako, F. Pucino, R. Wesley, and R. Loomba Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis Aliment Pharmacol Ther 35 2012 66 75
312. L.S. Bhatia, N.P. Curzen, and C.D. Byrne Nonalcoholic fatty liver disease and vascular risk Curr Opin Cardiol 27 2012 420 428
313. L.S. Bhatia, N.P. Curzen, P.C. Calder, and C.D. Byrne Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 33 2012 1190 1200
314. R. Weiss, S. Dufour, A. Groszmann, K. Petersen, J. Dziura, and S.E. Taksali et al. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation J Clin Endocrinol Metab 88 2003 2014 2018 (Pubitemid 36549870)
315. M. Gaggini, M. Morelli, E. Buzzigoli, R.A. DeFronzo, E. Bugianesi, and A. Gastaldelli Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease Nutrients 5 2013 1544 1560
316. R. Rahman, G.M. Hammoud, A.A. Almashhrawi, K.T. Ahmed, and J.A. Ibdah Primary hepatocellular carcinoma and metabolic syndrome: an update World J Gastrointest Oncol 5 2013 186 194
317. M.J. Chapman, H.N. Ginsberg, P. Amarenco, F. Andreotti, J. Boren, and A.L. Catapano et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management Eur Heart J 32 2011 1345 1361
318. M. Obika, and H. Noguchi Diagnosis and evaluation of nonalcoholic fatty liver disease Exp Diabetes Res 2012 2012 145754
319. S.A. Polyzos, J. Kountouras, A. Slavakis, E. Zafeiriadou, K. Patsiaoura, and E. Katsiki et al. A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study Biomarkers 2013
320. S. Siegert, Z. Yu, R. Wang-Sattler, T. Illig, J. Adamski, and J. Hampe et al. Diagnosing Fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers PLoS One 8 2013 e76813
321. J.S. Yang, J.T. Kim, J. Jeon, H.S. Park, G.H. Kang, and K.S. Park et al. Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice PLoS One 5 2010 e13858
322. P.R. Kenny, D.E. Brady, D.M. Torres, L. Ragozzino, N. Chalasani, and S.A. Harrison Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series Am J Gastroenterol 105 2010 2707 2709
323. S.A. Polyzos, J. Kountouras, E. Zafeiriadou, K. Patsiaoura, E. Katsiki, and G. Deretzi et al. Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease J Renin Angiotensin Aldosterone Syst 12 2011 498 503
324. B.M. Arendt, and J.P. Allard Effect of atorvastatin, vitamin E and C on nonalcoholic fatty liver disease: is the combination required? Am J Gastroenterol 106 2011 78 80
325. R. Jahn, and R.H. Scheller SNAREs - engines for membrane fusion Nat Rev Mol Cell Biol 7 2006 631 643 (Pubitemid 44268209)